SCHEMBL20044320

SCHEMBL20044320

Cc1c(F)cccc1NC(=O)[C@H]1C(=O)N(C)C[C@@H]1c1ccc(F)cc1

nearest known ligand 0.48

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.39
HTR1F P30939 1/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
MAPT P10636 1/20 0.38
ALDH1A1 P00352 3/20 0.37
LMNA P02545 1/20 0.37
HTR7 P34969 1/20 0.37
CXCR2 P25025 3/20 0.37
RAB9A P51151 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
TP53 P04637 1/20 0.35
GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20048568 0.94 THRB (0.41) THRBSMN1; SMN2MEN1KMT2AMAPT
SCHEMBL20044247 0.90 THRB (0.42) THRBSMN1; SMN2HTR1FMEN1KMT2A
SCHEMBL24310398 0.90 THRB (0.42) THRBSMN1; SMN2HTR1FMEN1KMT2A
SCHEMBL18815251 0.90 KMT2A (0.47) SMN1; SMN2MEN1KMT2AMAPTALDH1A1
SCHEMBL20044336 0.90 CXCR2 (0.39) THRBSMN1; SMN2MEN1KMT2AMAPT
SCHEMBL20044431 0.90 TRPM8 (0.40) THRBSMN1; SMN2MEN1KMT2AMAPT
SCHEMBL20044253 0.89 THRB (0.38) THRBSMN1; SMN2HTR1FMEN1KMT2A
SCHEMBL20043857 0.89 THRB (0.39) THRBSMN1; SMN2MEN1KMT2AMAPT
SCHEMBL20044088 0.89 THRB (0.39) THRBSMN1; SMN2MEN1KMT2AMAPT
SCHEMBL20044394 0.89 THRB (0.39) THRBSMN1; SMN2MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240025853-A1 SUBSTITUTED CYCLIC AMIDES AND THEIR USE AS HERBICIDES FMC CORPORATION 2024-01-25 US disclosed
US-20240025853-A1 SUBSTITUTED CYCLIC AMIDES AND THEIR USE AS HERBICIDES FMC CORPORATION 2024-01-25 US disclosed
US-11787765-B2 Substituted cyclic amides and their use as herbicides FMC CORPORATION (US) 2023-10-17 US disclosed
US-11787765-B2 Substituted cyclic amides and their use as herbicides FMC CORPORATION (US) 2023-10-17 US disclosed
US-20220127229-A1 SUBSTITUTED CYCLIC AMIDES AND THEIR USE AS HERBICIDES FMC CORPORATION 2022-04-28 US disclosed
US-10654804-B2 Substituted cyclic amides and their use as herbicides FMC CORPORATION (US) 2020-05-19 US disclosed
US-20180099935-A1 SUBSTITUTED CYCLIC AMIDES AND THEIR USE AS HERBICIDES FMC CORPORATION 2018-04-12 US disclosed
US-20180099935-A1 SUBSTITUTED CYCLIC AMIDES AND THEIR USE AS HERBICIDES FMC CORPORATION 2018-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11787765-B2 Substituted cyclic amides and their use as herbicides NIT2, ARG1, CNPY2 THRB 2171/4885SMN1; SMN2 4288/4885HTR1F 3726/4885
US-20180099935-A1 SUBSTITUTED CYCLIC AMIDES AND THEIR USE AS HERBICIDES NIT2, ARG1, CNPY2 THRB 2171/4885SMN1; SMN2 4288/4885HTR1F 3726/4885
US-10654804-B2 Substituted cyclic amides and their use as herbicides NIT2, ARG1, CNPY2 THRB 2171/4885SMN1; SMN2 4288/4885HTR1F 3726/4885
US-20240025853-A1 SUBSTITUTED CYCLIC AMIDES AND THEIR USE AS HERBICIDES NIT2, ARG1, CNPY2 THRB 2193/4885SMN1; SMN2 4295/4885HTR1F 3712/4885
US-20220127229-A1 SUBSTITUTED CYCLIC AMIDES AND THEIR USE AS HERBICIDES NIT2, ARG1, CNPY2 THRB 2171/4885SMN1; SMN2 4288/4885HTR1F 3726/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.